Literature DB >> 8962723

Umbilical cord transforming growth factor-beta 3: isolation, comparison with recombinant TGF-beta 3 and cellular localization.

A A Stewart1, J D Haley, G Y Qu, K Stam, D Fenyö, B T Chait, D R Marshak, A Y Ng, G Marley, K K Iwata.   

Abstract

The transforming growth factor beta (TGF-beta) family of growth modulators play critical roles in tissue development and maintenance. Recent data suggest that individual TGF-beta isoforms (TGF-beta 1, -beta 2 and -beta 3) have overlapping yet distinct biological actions and target cell specificities, both in developing and adult tissues. The TGF-beta 3 isoform was purified to homogeneity from both natural and recombinant sources and characterized by laser desorption mass spectrometry, by protein sequencing, by amino acid analysis and by biological activity. TGF-beta 3 was the major TGF-beta isoform in umbilical cord (230 ng/g), and was physically and biologically indistinguishable from recombinant TGF-beta 3 and from the tumor growth inhibitory (TGI) protein found in umbilical cord. Immunohistochemistry using antipeptide TGF-beta 3 specific antibody showed TGF-beta 3 localization in perivascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962723     DOI: 10.3109/08977199609034569

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  2 in total

1.  Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro.

Authors:  C A Squier; M J Kremer; A Bruskin; A Rose; J D Haley
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

2.  Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds.

Authors:  Alexander Stoff; Angel A Rivera; J Michael Mathis; Steven T Moore; N S Banerjee; Maaike Everts; Antonio Espinosa-de-los-Monteros; Zdenek Novak; Luis O Vasconez; Thomas R Broker; Dirk F Richter; Dale Feldman; Gene P Siegal; Mariam A Stoff-Khalili; David T Curiel
Journal:  J Mol Med (Berl)       Date:  2007-01-12       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.